Alexander Egle

7.3k total citations
153 papers, 4.2k citations indexed

About

Alexander Egle is a scholar working on Genetics, Oncology and Molecular Biology. According to data from OpenAlex, Alexander Egle has authored 153 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Genetics, 48 papers in Oncology and 43 papers in Molecular Biology. Recurrent topics in Alexander Egle's work include Chronic Lymphocytic Leukemia Research (63 papers), Lymphoma Diagnosis and Treatment (37 papers) and Multiple Myeloma Research and Treatments (15 papers). Alexander Egle is often cited by papers focused on Chronic Lymphocytic Leukemia Research (63 papers), Lymphoma Diagnosis and Treatment (37 papers) and Multiple Myeloma Research and Treatments (15 papers). Alexander Egle collaborates with scholars based in Austria, Germany and United States. Alexander Egle's co-authors include Richard Greil, Suzanne Cory, Andreas Villunger, Thomas Melchardt, Philippe Bouillet, Alan W. Harris, Josefina Piñón Hofbauer, Marion Kos, Inge Tinhofer and I Marschitz and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Genes & Development.

In The Last Decade

Alexander Egle

147 papers receiving 4.1k citations

Peers

Countries citing papers authored by Alexander Egle

Since Specialization

Citations

This map shows the geographic impact of Alexander Egle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexander Egle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexander Egle more than expected).

Fields of papers citing papers by Alexander Egle

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexander Egle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexander Egle. The network helps show where Alexander Egle may publish in the future.

Co-authorship network of co-authors of Alexander Egle

This figure shows the co-authorship network connecting the top 25 collaborators of Alexander Egle. A scholar is included among the top collaborators of Alexander Egle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexander Egle. Alexander Egle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Oncogenic MTOR Signaling Axis Compensates BTK Inhibition in a Chronic Lymphocytic Leukemia Patient with Richter Transformation: A Case Report and Review of the Literature 2024 ·Acta Haematologica ·(unknown), (unknown), (unknown), Franz Josef Gassner, Maria Schubert, M. Steiner, (unknown), (unknown), (unknown), (unknown), Daniel Neureiter, Lisa Pleyer, Alexander Egle, Richard Greil, Roland Geisberger, Nadja Zaborsky	1
2	Myeloid NGS Analyses of Paired Samples from Bone Marrow and Peripheral Blood Yield Concordant Results: A Prospective Cohort Analysis of the AGMT Study Group 2023 ·Cancers ·(unknown), Michael Leisch, Franz Josef Gassner, Nadja Zaborsky, (unknown), Sonja Hutter, Angela Risch, Thomas Melchardt, Alexander Egle, (unknown), Julian Larcher‐Senn, Richard Greil, Lisa Pleyer	12
3	How I treat diffuse large B-cell lymphoma 2023 ·ESMO Open ·Thomas Melchardt, Alexander Egle, Richard Greil	25
4	Transcriptomic Profiling Identifies CD8+ T Cells in the Brain of Aged and Alzheimer’s Disease Transgenic Mice as Tissue-Resident Memory T Cells 2022 ·The Journal of Immunology ·Barbara Altendorfer, Michael S. Unger, Rodolphe Poupardin, (unknown), Daniela Asslaber, Iris K. Gratz, Heike Mrowetz, (unknown), (unknown), Richard Greil, Alexander Egle, David Gate, Tony Wyss‐Coray, Ludwig Aigner	39
5	A POLE Splice Site Deletion Detected in a Patient with Biclonal CLL and Prostate Cancer: A Case Report 2021 ·International Journal of Molecular Sciences ·M. Steiner, Franz Josef Gassner, (unknown), Daniel Neureiter, Alexander Egle, Roland Geisberger, Richard Greil, Nadja Zaborsky	2
6	Clonal evolution in diffuse large B-cell lymphoma with central nervous system recurrence 2021 ·ESMO Open ·Teresa Magnes, (unknown), Aaron R. Thorner, Daniel Neureiter, E. Klieser, Gabriel Rinnerthaler, (unknown), Florian Huemer, Nadja Zaborsky, M. Steiner, Stefan Weis, Richard Greil, Alexander Egle, Thomas Melchardt	10
7	Vinorelbine as substitute for vincristine in patients with diffuse large B cell lymphoma and vincristine-induced neuropathy 2021 ·Supportive Care in Cancer ·Stefan Hatzl, Florian Posch, (unknown), (unknown), Christine Beham‐Schmid, (unknown), (unknown), Alexander Deutsch, Hildegard Greinix, Barbara Uhl, Katharina Prochazka, Alexander Egle, Richard Greil, Thomas Melchardt, Werner Linkesch, Eduard Schulz, Peter Neumeister	6
8	Postoperative chemoradiotherapy with cisplatin is superior to radioimmunotherapy with cetuximab and radiotherapy alone 2021 ·Wiener klinische Wochenschrift ·Teresa Magnes, (unknown), Thomas Melchardt, Lukas Weiß, Gabriel Rinnerthaler, Florian Huemer, Michael Kopp, Simon Peter Gampenrieder, (unknown), Thorsten Füreder, (unknown), Johannes Andel, Alexander Egle, Richard Greil	5
9	Stromal cell protein kinase C-β inhibition enhances chemosensitivity in B cell malignancies and overcomes drug resistance 2020 ·Science Translational Medicine ·Eugene Park, (unknown), A. P. Moore, (unknown), Antonella Santoro, Joseph R. Boyd, Hilde Schjerven, Veronika Ecker, Maike Buchner, James C. Williamson, Paul J. Lehner, Luca Gasparoli, Owen Williams, Johannes Bloehdorn, Stephan Stilgenbauer, Michael Leitges, Alexander Egle, Marc Schmidt‐Supprian, Seth Frietze, Ingo Ringshausen	22
10	RNA editing contributes to epitranscriptome diversity in chronic lymphocytic leukemia 2020 ·Leukemia ·Franz Josef Gassner, Nadja Zaborsky, Ilana Buchumenski, Erez Y. Levanon, (unknown), Maria Schubert, (unknown), Daniel Hebenstreit, Ferran Nadeu, Elı́as Campo, Alexander Egle, Richard Greil, Roland Geisberger	22
11	BIRC3 Expression Predicts CLL Progression and Defines Treatment Sensitivity via Enhanced NF-κB Nuclear Translocation 2018 ·Clinical Cancer Research ·Daniela Asslaber, (unknown), Michael Leisch, Yuan Qi, Nicole Maeding, Clemens Hufnagl, (unknown), Nadja Zaborsky, Andreas Villunger, Tanja Nicole Hartmann, Richard Greil, Alexander Egle	32
12	Health-Related Quality of Life in Patients with Relapsed/Refractory Multiple Myeloma during Treatment with Ixazomib-Thalidomide-Dexamethasone Followed By Ixazomib Maintenance 2017 ·Blood ·Heinz Ludwig, Wolfram Pönisch, Alexander Egle, Stefan Knop, Martin Schreder, Daniel Lechner, Roman Hájek, Eberhard Gunsilius, Michael Fridrik, Andreas Petzer, Katja Weisel, Dietger Niederwieser, Axel Hinke, Richard Greil, Niklas Zojer	1
13	Milestones in Chronic Lymphocytic Leukemia 2017 ·memo - Magazine of European Medical Oncology ·Alexander Egle	0
14	The influence of FCGR2A and FCGR3A polymorphisms on the survival of patients with recurrent or metastatic squamous cell head and neck cancer treated with cetuximab 2017 ·The Pharmacogenomics Journal ·Teresa Magnes, Thomas Melchardt, Clemens Hufnagl, (unknown), Christof Mittermair, Daniel Neureiter, E. Klieser, Gabriel Rinnerthaler, (unknown), Alexander Gaggl, Richard Greil, Alexander Egle	18
15	ILK Induction in Lymphoid Organs by a TNFα–NF-κB–Regulated Pathway Promotes the Development of Chronic Lymphocytic Leukemia 2016 ·Cancer Research ·Peter W. Krenn, Sebastian W. Hofbauer, (unknown), (unknown), (unknown), Ursula Denk, Daniela Asslaber, (unknown), Christina Sternberg, Daniel Neureiter, Fritz Aberger, Sara A. Wickström, Alexander Egle, Richard Greil, Tanja Nicole Hartmann	12
16	Independent Prognostic Value of Serum Markers in Diffuse Large B-Cell Lymphoma in the Era of the NCCN-IPI 2015 ·Journal of the National Comprehensive Cancer Network ·Thomas Melchardt, Katharina Troppan, Lukas Weiß, Clemens Hufnagl, Daniel Neureiter, Wolfgang Tränkenschuh, Konstantin Schlick, Florian Huemer, Alexander Deutsch, Peter Neumeister, Richard Greil, Martin Pichler, Alexander Egle	25
17	How does lenalidomide target the chronic lymphocytic leukemia microenvironment? 2014 ·Blood ·Arnon P. Kater, Sanne H. Tonino, Alexander Egle, Alan G. Ramsay	46
18	An uncommon cause of anaemia: Sheehan's syndrome 2010 ·Wiener klinische Wochenschrift ·Thomas Melchardt, (unknown), Lukas Weiß, Alexander Egle, (unknown), Richard Greil	4
19	Bim and Bmf in tissue homeostasis and malignant disease 2008 ·Oncogene ·Josefina Piñón Hofbauer, Verena Labi, Alexander Egle, Andreas Villunger	102
20	Functional granulocyte/macrophage colony stimulating factor receptor is constitutively expressed on neoplastic plasma cells and mediates tumour cell longevity 1998 ·British Journal of Haematology ·Andreas Villunger, Alexander Egle, Marion Kos, Daniel Egle, Inge Tinhofer, Traudl Henn, Florian Überall, Karl Maly, Richard Greil	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact